Mevion Medical looks to go public with a $69 million stock offering as it gears up to scale its proton therapy device.
Mevion Medical registered for a $69 million initial public offering as it gears up to commercialize its proton therapy system.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rTmP3c
Cap comentari:
Publica un comentari a l'entrada